Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events

Researchers analyzed data from 154,779 patients who underwent cardiac MRI, 95% of whom received a gadolinium-based contrast agent

Contrast Reaction Raises Contrast Risk

Patient Safety - Page 4 of 20 - Express Healthcare

Tomography, Free Full-Text

Safety and clinical usefulness of gadoteric acid including post-m

Frontiers Predicting post-contrast information from contrast

Cardiac Manifestations COVID-19

IJMS, Free Full-Text

A cardiovascular magnetic resonance imaging-based pilot study to

Cardiac MRI Contrast Agents Carry Low Risk of Adverse Events